Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GSK · against 557 other Healthcare companies listed in US-listed
Ranked #62 of 558 · scores higher than 89% of peers
Bars: peers in each 10-point band of the profitability score38 peers with a profitability score of 80–89, including GSK · Click a bar to see the companies
Mainly thanks to its return on assets, operating margin and return on invested capital, which are stronger than most Healthcare peers.
| Metric | GSK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 20.4% | -7.0% | 88% | 33% | |
| Operating marginHigher is better · 479 reported | 24.3% | -2.4% | 89% | 33% | |
| Return on assetsHigher is better · 582 reported | 9.4% | -7.8% | 86% | 33% | |
| Return on equityHigher is better · 531 reported | 33.4% | -19.7% | 93% | Context only | |
| Gross marginHigher is better · 601 reported | 73.5% | 43.9% | 77% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 53 | 528M USD | 90 | 58 | |
| 53 | 10.7B USD | 90 | 65 | |
| 53 | 21.5B USD | 90 | 60 | |
| 53 | 49.1B USD | 90 | 69 | |
| 62 | 97.5B USD | 89 | 67 | |
| 62 | 36.0B USD | 89 | 46 | |
| 62 | 2.2B USD | 89 | 66 | |
| 62 | 14.4B USD | 89 | 71 | |
| 66 | 126.1B USD | 88 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score